home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences


  IBC's Cell-Based Assays & Screening  
  August 21, 2002

Biochemistry / Immunology

  -, Philadelphia, PA
December 4-6, 2002

At this inaugural meeting, a group of leading scientists from Merck, Johnson & Johnson, AstraZeneca, Bayer, Sugen, GlaxoSmithKline, among others, will provide their insights into the significance of cell-based assays to their research. With a Pre-Conference symposium on “Cell Culture & Analaysis,” and main conference sessions focussing on real-world case studies; novel screening platforms; cell-imaging technologies and future applications of micro- & nano-technology in cell-based assays, this 3-day event aims to share the secrets and uncover the breakthroughs in the drug discovery and development process.
Organized by: IBC Life Sciences
Invited Speakers: Scientific Advisory Board

Lisa Minor, Ph.D., Johnson & Johnson Pharmaceuticals
Jim Inglese, Ph.D., Merck Research Laboratories
Yingfei Wei, Ph.D., Bayer Biotechnology
Patricia A. Kasila, PerkinElmer Life Sciences
Deadline for Abstracts: -
Registration: Five Easy Ways to Register!
Phone (508) 616-5550
Fax (508) 616-5522
E-mail reg@ibcusa.com
IBC USA Conferences, Inc.
One Research Drive
Suite 400A
Westborough, MA 01581-5195
E-mail: reg@ibcusa.com
  Posted by:   James G. Prudhomme  
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2002 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.